Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7M3E | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M3F | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M3G | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M3G | 7M3G | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M3I | 7M3I | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
| 7M3I | P0DTC2 | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
| 7M3J | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M42 | 7M42 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
| 7M42 | P0DTC2 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
| 7M5E | A0A140AYW5 | MERS-CoV S bound to the broadly neutralizing B6 Fab fragment (C3 refinement) | |
| 7M5V | Q9NQ11 | human ATP13A2 in the AMPPNP-bound occluded state | |
| 7M5X | Q9NQ11 | Human ATP13A2 in the outward-facing E2 state bound to spermine and beryllium fluoride | |
| 7M5Y | Q9NQ11 | human ATP13A2 in the outward-facing E2 state bound to spermine and magnesium fluoride | |
| 7M6D | 7M6D | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 | |
| 7M6D | P0DTC2 | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 | |
| 7M6E | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | |
| 7M6E | 7M6E | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | |
| 7M6F | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | |
| 7M6F | 7M6F | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | |
| 7M6G | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | |
| 7M6G | 7M6G | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | |
| 7M6H | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | |
| 7M6H | 7M6H | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | |
| 7M6I | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 | |
| 7M6I | 7M6I | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 | |
| 7M6M | O93430 | Full length alpha1 Glycine receptor in presence of 32uM Tetrahydrocannabinol | |
| 7M6N | O93430 | Full length alpha1 Glycine receptor in presence of 0.1mM Glycine | |
| 7M6O | O93430 | Full length alpha1 Glycine receptor in presence of 0.1mM Glycine and 32uM Tetrahydrocannabinol | |
| 7M6P | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine | |
| 7M6Q | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 1 | |
| 7M6R | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 2 | |
| 7M6S | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 3 | |
| 7M71 | P0DTC2 | SARS-CoV-2 Spike:5A6 Fab complex I focused refinement | |
| 7M71 | 7M71 | SARS-CoV-2 Spike:5A6 Fab complex I focused refinement | |
| 7M72 | P11609 | MHC-like protein complex structure | |
| 7M72 | P01887 | MHC-like protein complex structure | |
| 7M72 | K7N5N2 | MHC-like protein complex structure | |
| 7M72 | 7M72 | MHC-like protein complex structure | |
| 7M72 | K7N5N2 | MHC-like protein complex structure | |
| 7M72 | 7M72 | MHC-like protein complex structure | |
| 7M72 | K7N5M4 | MHC-like protein complex structure | |
| 7M72 | K7N5M4 | MHC-like protein complex structure | |
| 7M74 | 7M74 | ATP-bound AMP-activated protein kinase | |
| 7M74 | O43741 | ATP-bound AMP-activated protein kinase | |
| 7M74 | P54619 | ATP-bound AMP-activated protein kinase | |
| 7M74 | A0A6D0N546 | ATP-bound AMP-activated protein kinase | |
| 7M75 | P0A405 | Room Temperature XFEL Crystallography reveals asymmetry in the vicinity of the two phylloquinones in Photosystem I | |
| 7M75 | P0A407 | Room Temperature XFEL Crystallography reveals asymmetry in the vicinity of the two phylloquinones in Photosystem I | |
| 7M75 | P0A415 | Room Temperature XFEL Crystallography reveals asymmetry in the vicinity of the two phylloquinones in Photosystem I | |
| 7M75 | P0A420 | Room Temperature XFEL Crystallography reveals asymmetry in the vicinity of the two phylloquinones in Photosystem I |
